LN-890033
BENZAMIDE, N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-2-HYDROXY-3-IODO-6-METHOXY- , 84226-06-2
Update time: 2023-04-23
PRODUCT Properties
Boiling point: | 426.9±45.0 °C(Predicted) |
Density | 1.510±0.06 g/cm3(Predicted) |
storage temp. | 2-8°C |
solubility | H2O: <0.5 mg/mL, slightly soluble |
form | oil |
pka | 6.40±0.40(Predicted) |
color | dark yellow |
Description and Uses
A halogenated benzamide derivative as potential radioligands for non-invasive quantification of D2-like dopamine receptor. The main purpose of a brain study with IBZM is the differentiation of Parkinson’s disease from other neurodegenerative diseases like Lewy Body dementia, multiple system atrophy.
Safety
WGK Germany | 3 |